Pharmacy
NACDS: Initial findings of FTC’s PBM study demand action
National Association of Chain Drug Stores president and CEO Steven Anderson issued the following statement after the Federal Trade Commission’s (FTC) release today of an interim staff report on the harmful tactics of pharmacy benefit managers (PBM) – the pharmaceutical middlemen: “The FTC’s initial
Dr. Reddy’s Lopez on optimizing customer service
Tracy Lopez, who is the head of North America customer service and 3 PL operations at Dr. Reddy’s Laboratories,spoke with Chain Drug Review about her role and how the company maximizes customer satisfaction. CDR: Can you explain what 3 PL operations is? LOPEZ: It’s third-party logistics.
Revelation Pharma buys Taylors Pharmacy and Key Compounding
Revelation Pharma announced it has acquired Taylors Pharmacy, a thriving nationwide independent pharmacy based in Florida and licensed in over 41 states, and Washington-based Key Compounding Pharmacy, a staple in and around its Federal Way location.
NCPA launches powerful new TV ad: “PBM Career Day”
ALEXANDRIA, Va. – The National Community Pharmacists Association today released a new television advertisement as part of its ongoing campaign to push lawmakers to enact pharmacy benefit manager reform, which has bipartisan support in both chambers of Congress.
Discussing solutions to address drug shortages
HDA recently partnered with The Hill to facilitate a dialogue between government leaders and policy experts on the causes of drug shortages and potential solutions. The event, “Keeping Pharmacy Shelves Filled: Solutions to Address Drug Shortages,” included speakers Rep. Larry Buschon, MD (R-Ind.
Walmart Health shopping vacant clinics
According to published reports, Walmart is in the the process of seeking buyers for its vacant health clinics, wrote Fortune magazine. Currently, buildings associated with the defunct Walmart Health division are empty and patients have had to seek care elsewhere.
Albertsons taps Soda Health to bring Medicare Advantage Benefits online
CHICAGO – Albertsons Cos. and Soda Health announce a new expanded service offering, making it even easier for Medicare Advantage members to use their supplemental benefits. Soda Health is the first and currently only benefits card to be accepted by Albertsons.
American Regent introduces Sodium Phosphates Injection
American Regent announces the launch and availability of Sodium Phosphates Injection, USP, which is FDA-approved and therapeutically equivalent to Sodium Phosphates.
Upsher-Smith debuts enhanced rare disease support program
Upsher-Smith has debuted its enhanced Promise of Support Program – a patient-centered program designed to offer patients, caregivers, and healthcare providers in the rare disease community comprehensive support throughout the treatment journey.
Regeneron, Sanofi: EU approves Dupixent as first-ever targeted therapy for COPD patients
The European Medicines Agency (EMA) has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease (COPD) characterized by raised blood eosinophils.
Aurigene to partner with Edity Therapeutics in cell therapy
Aurigene’s parent company, Dr. Reddy’s Laboratories, has recently made a strategic investment in Edity and will provide discovery services in cell therapy to the company.
Novo Nordisk to build a facility in Clayton, NC
Novo Nordisk will invest $4.1 billion to build a second fill and finishing manufacturing facility in Clayton, North Carolina. The move will help the company grow its ability to produce current and future injectable treatments for people with obesity and other serious chronic diseases.
Court rejects plan to shield Sacklers in Purdue opioid deal
The Supreme Court on Thursday rejected a nationwide settlement with OxyContin maker Purdue Pharma that would have shielded members of the Sackler family who own the company from civil lawsuits over the toll of opioids but also would have provided billions of dollars to combat the opioid epidemic.